UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 12.145

Sortiert nach

Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880-2018: A Systematic Review

Clinical infectious diseases, 2022-10, Vol.75 (Suppl 3), p.S341-S353

2022

Link zum Volltext

Verfügbarkeit prüfen

Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults

Emerging infectious diseases, 2014-02, Vol.20 (2)

2014

Link zum Volltext

Verfügbarkeit prüfen

Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model

Infection and immunity, 2020-07, Vol.88 (8)

2020

Link zum Volltext

Verfügbarkeit prüfen

Anthrax Pathogenesis

Annual review of microbiology, 2015-10, Vol.69 (1), p.185-208

2015

Link zum Volltext

Verfügbarkeit prüfen

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity

European journal of pharmaceutics and biopharmaceutics, 2015-06, Vol.93, p.149-164

2015

Link zum Volltext

Verfügbarkeit prüfen

Anthrax prevention through vaccine and post-exposure therapy

Expert opinion on biological therapy, 2020-12, Vol.20 (12), p.1405-1425

2020

Link zum Volltext

Verfügbarkeit prüfen

Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins

Proceedings of the National Academy of Sciences - PNAS, 2010-11, Vol.107 (44), p.19002-19007

2010

Link zum Volltext

Verfügbarkeit prüfen

Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax

Frontiers in immunology, 2018-03, Vol.9, p.562

2018

Link zum Volltext

Verfügbarkeit prüfen

Spatial analysis of human and livestock anthrax in Lai Chau province, Vietnam (2004–2021)

Acta tropica, 2024-01, Vol.249, p.107044-107044, Article 107044

2024

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults

Vaccine, 2016-04, Vol.34 (18), p.2096-2105

2016

Link zum Volltext

Verfügbarkeit prüfen

Anthrax:an update

Asian Pacific journal of tropical biomedicine, 2011-12, Vol.1 (6), p.496-501

2011

Link zum Volltext

Verfügbarkeit prüfen

BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis

Molecular microbiology, 2010-01, Vol.75 (2), p.324-332

2010

Link zum Volltext

Verfügbarkeit prüfen

Spatial epidemiology of human anthrax in Son La province, Vietnam, 2003–2022

Zoonoses and public health, 2024-06, Vol.71 (4), p.392-401

2024

Link zum Volltext

Verfügbarkeit prüfen

Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum

PloS one, 2016-04, Vol.11 (4), p.e0153956-e0153956

2016

Link zum Volltext

Verfügbarkeit prüfen

Anthrax as a biological weapon, 2002: updated recommendations for management

JAMA : the journal of the American Medical Association, 2002-05, Vol.287 (17), p.2236

2002

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Spatial distribution of Human and Livestock Anthrax in Cao Bang Province, Vietnam (2004-2020)

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2023-05, Vol.23 (5), p.306

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the adaptive immune response of donors receiving live anthrax vaccine

PloS one, 2021-12, Vol.16 (12), p.e0260202-e0260202

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers

Vaccine, 2013-06, Vol.31 (30), p.3051-3058

2013

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009-2010

Emerging infectious diseases, 2017-01, Vol.23 (1), p.56-65

2017

Link zum Volltext

Verfügbarkeit prüfen

Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation Anthrax

Clinical infectious diseases, 2022-10, Vol.75 (Suppl 3), p.S364-S372

2022

Link zum Volltext

Verfügbarkeit prüfen

Modeling the environmental suitability of anthrax in Ghana and estimating populations at risk: Implications for vaccination and control

PLoS neglected tropical diseases, 2017-10, Vol.11 (10), p.e0005885-e0005885

2017

Link zum Volltext

Verfügbarkeit prüfen

The global distribution of Bacillus anthracis and associated anthrax risk to humans, livestock and wildlife

Nature microbiology, 2019-08, Vol.4 (8), p.1337

2019

Link zum Volltext

Verfügbarkeit prüfen

Rapid Vaccination Using an Acetalated Dextran Microparticulate Subunit Vaccine Confers Protection Against Triplicate Challenge by Bacillus Anthracis

Pharmaceutical research, 2013-05, Vol.30 (5), p.1349-1361

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of ANTHRASIL

PloS one, 2023-03, Vol.18 (3), p.e0283164

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults

PloS one, 2010-11, Vol.5 (11), p.e13849

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 12.145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.646)
Mit Volltextzugriff
(8.118)

Publikationsform

7 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.897)
EZB Electronic Journals Library
(4.294)
NUS Single-Journal Subscriptions
(3.175)
Ingenta
(2.750)
Nexis Uni
(2.539)
Journals@Ovid Complete
(2.033)
Jstor Complete Legacy
(1.748)
IngentaConnect Journals
(1.310)
Elsevier ScienceDirect Journals Complete
(1.148)
EBSCOhost Business Source Ultimate
(1.100)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(930)
Wiley Online Library Journals Frontfile Complete
(773)
Wiley Online Library Full Collection 2018
(491)
Oxford University Press Journals Current
(433)
Springer Nature - Complete Springer Journals
(431)
BMJ Publishing
(404)
PAIS Index
(329)
Ebook Central Perpetual and DDA
(279)
eBooks on EBSCOhost
(279)
Taylor & Francis
(273)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

British Medical Journal
(312)
Vaccine
(198)
Science
(183)
Žurnal Mikrobiologii, Ėpidemiologii I Immunobiologii
(182)
Plos One
(179)
Bmj
(149)
Infection And Immunity
(146)
Emerging Infectious Diseases
(125)
Inside The Pentagon
(117)
Proceedings Of The National Academy Of Sciences - Pnas
(114)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(10)
... seit 90 Tagen
(43)

Menü

Weitere Dienste

Einstellungen

Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880-2018: A Systematic Review

Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults

Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model

Anthrax Pathogenesis

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity

Anthrax prevention through vaccine and post-exposure therapy

Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins

Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax

Spatial analysis of human and livestock anthrax in Lai Chau province, Vietnam (2004–2021)

Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults

Anthrax:an update

BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis

Spatial epidemiology of human anthrax in Son La province, Vietnam, 2003–2022

Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum

Anthrax as a biological weapon, 2002: updated recommendations for management

Incidence and Spatial distribution of Human and Livestock Anthrax in Cao Bang Province, Vietnam (2004-2020)

Characterization of the adaptive immune response of donors receiving live anthrax vaccine

Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers

Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009-2010

Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation Anthrax

Modeling the environmental suitability of anthrax in Ghana and estimating populations at risk: Implications for vaccination and control

The global distribution of Bacillus anthracis and associated anthrax risk to humans, livestock and wildlife

Rapid Vaccination Using an Acetalated Dextran Microparticulate Subunit Vaccine Confers Protection Against Triplicate Challenge by Bacillus Anthracis

Efficacy of ANTHRASIL

Phase I study of safety and immunogenicity of an Escherichia coli-derived recombinant protective antigen (rPA) vaccine to prevent anthrax in adults

Suchergebnisse filtern